Sanara MedTech

Fort Worth, United States Founded: 1982 • Age: 44 yrs
Developer of therapeutics for infectious disease
Request Access

About Sanara MedTech

Sanara MedTech is a company based in Fort Worth (United States) founded in 1982.. The company has 141 employees as of December 31, 2024. Sanara MedTech has completed 2 acquisitions, including Precision Healing and Scendia Biologics. Sanara MedTech offers products and services including CellerateRX® Surgical Powder, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, TEXAGEN® Amniotic Membrane Allograft, and BIAKŌS® Antimicrobial Wound Gel. Sanara MedTech operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.

  • Headquarter Fort Worth, United States
  • Employees 141 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Sanara Medtech Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $86.67 M
    33.36
    as on Dec 31, 2024
  • Net Profit
    $-9.66 M
    -124.59
    as on Dec 31, 2024
  • EBITDA
    $-3.73 M
    6.5
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    141

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Sanara MedTech

Sanara MedTech is a publicly listed company on the NASDAQ with ticker symbol SMTI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: SMTI . Sector: Health technology · USA

Products & Services of Sanara MedTech

Sanara MedTech offers a comprehensive portfolio of products and services, including CellerateRX® Surgical Powder, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, TEXAGEN® Amniotic Membrane Allograft, and BIAKŌS® Antimicrobial Wound Gel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Aids in natural healing of surgical wounds using hydrolyzed collagen.

Reinforces soft tissue through porcine submucosa implantation.

Provides micronized matrix for managing surgical wounds effectively.

Serves as a barrier for various soft tissue applications.

Disrupts biofilms to aid in wound healing and microbe elimination.

People of Sanara MedTech
Headcount 10-50
Employee Profiles 48
Employee Profiles
People
Matthew Cole
Midwest Regional Bone Biologics Specialist
People
Kaley Goane
Medical Sales Representative
People
Natalie Derose
Territory Manager
People
Bill Fitzgerald
Chief Compliance Officer

Unlock access to complete

Funding Insights of Sanara MedTech

  • Total Funding
  • Total Rounds
    -
  • Last Round
  • First Round
  • Investors Count

Investments & Acquisitions by Sanara MedTech

Sanara MedTech has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Precision Healing and Scendia Biologics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Bone minerals and traditional grafts are manufactured by Scendia Biologics.
2016
Therapeutic massage services are provided in Portland, United States.
2011
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Sanara MedTech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sanara Medtech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sanara MedTech

Sanara MedTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Vaccines and therapeutics for multiple diseases are developed and marketed.
domain founded_year HQ Location
Developer of therapeutics for the treatment of infectious diseases
domain founded_year HQ Location
Vaccines for infectious diseases are developed using cell-free protein synthesis.
domain founded_year HQ Location
Novel anti-infectives for bacterial and fungal infections are developed.
domain founded_year HQ Location
Gene therapy platform is developed for chronic disease treatments.
domain founded_year HQ Location
Prophylactic vaccines for infectious diseases are developed and advanced.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Sanara MedTech

When was Sanara MedTech founded?

Sanara MedTech was founded in 1982.

Where is Sanara MedTech located?

Sanara MedTech is headquartered in Fort Worth, United States. It is registered at Fort Worth, Texas, United States.

How many employees does Sanara MedTech have?

As of Dec 31, 2024, the latest employee count at Sanara MedTech is 141.

What is the annual revenue of Sanara MedTech?

Annual revenue of Sanara MedTech is $86.67M as on Dec 31, 2024.

What does Sanara MedTech do?

Developer of therapeutics for infectious disease. The platform has developed wound care products that include BIAKŌS for antimicrobial skin and wound cleaning and PULSAR II is the wound irrigation system. The platform also developed surgical products that include CellerateRX is surgical powder.

Who are the top competitors of Sanara MedTech?

Sanara MedTech's top competitors include Vaxcyte, Serum Institute of India and Biological E.

What products or services does Sanara MedTech offer?

Sanara MedTech offers CellerateRX® Surgical Powder, FORTIFY TRG® Tissue Repair Graft, FORTIFY FLOWABLE® Extracellular Matrix, TEXAGEN® Amniotic Membrane Allograft, and BIAKŌS® Antimicrobial Wound Gel.

Is Sanara MedTech publicly traded?

Yes, Sanara MedTech is publicly traded on NASDAQ under the ticker symbol SMTI.

How many acquisitions has Sanara MedTech made?

Sanara MedTech has made 2 acquisitions, including Precision Healing, and Scendia Biologics.

What is Sanara MedTech's ticker symbol?

The ticker symbol of Sanara MedTech is SMTI on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available